AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Arvex-ER 37.5 Capsule

Prescription Icon
Prescription Required

Marketer

Aeras Pharma

Salt Composition

Venlafaxine (37.5mg)

Overview Arvex-ER 37.5 Capsule

Deprexa-XL 37.5mg capsules treat depression and anxiety. This medication modifies brain chemistry, alleviating anxiety symptoms like agitation, edginess, poor focus, tiredness, perspiration, rapid heartbeat, and racing thoughts. Take Deprexa-XL 37.5mg with food, consistently at the same time daily for steady blood levels. Missed doses should be taken immediately upon recall; don't skip doses and complete the prescribed course, even if feeling improved. Abrupt cessation can exacerbate symptoms. Possible side effects include queasiness, vomiting, sleep disturbances, reduced appetite, heightened anxiety, bowel irregularity, increased sweating, and sexual difficulties. Drowsiness and dizziness may occur; avoid driving or mentally demanding tasks until the effects are known. These are usually transient and self-limiting. Consult your physician if side effects persist or are troubling. Prior to starting Deprexa-XL 37.5mg, disclose any kidney, heart, or liver issues, or history of seizures. Report any unusual mood or behavioral shifts, worsening depression, or suicidal ideation to your doctor immediately.

Uses of Arvex-ER 37.5 Capsule

Mood disorders encompassing sadness and worry.

Major Benefits of Arvex-ER 37.5 Capsule:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the capsule whole; avoid chewing, crushing, or fracturing it. Arvex-ER 37.5 Capsules should be administered with a meal.

Common Side effects of Arvex-ER 37.5 Capsule:

  • Nausea
  • Vomiting
  • Dizziness
  • Insomnia (difficulty in sleeping)
  • Decreased appetite
  • Anxiety
  • Constipation
  • Increased sweating
  • Sexual dysfunction

How to use Arvex-ER 37.5 Capsule:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the capsule whole; avoid chewing, crushing, or breaking it. Arvex-ER 37.5 Capsules should be administered with a meal.

How Arvex-ER 37.5 Capsule works:

Arvex-ER 37.5 mg capsules elevate brain levels of serotonin and noradrenaline, neurotransmitters crucial for emotional equilibrium.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Arvex-ER 37.5 Capsules is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Arvex-ER 37.5 Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before using this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Arvex-ER 37.5 Capsule while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant. Close observation of infants for drowsiness and healthy weight increase is recommended.

DrivingDrivingUNSAFE

Driving ability may be impaired by Arvex-ER 37.5 Capsule side effects. These side effects include dizziness, confusion, and visual disturbances like blurred vision, all of which can impact driving safety.

KidneyKidneyCAUTION

Patients with kidney impairment should use Arvex-ER 37.5mg capsules cautiously, potentially requiring a modified dosage. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Arvex-ER 37.5 Capsules. Dosage modification may be necessary; physician consultation is advised.

What if you forget to take Arvex-ER 37.5 Capsule :

Should you forget to take a dose of Arvex-ER 37.5 Capsule, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Arvex-ER 37.5 Capsule

LabelValue
Type of Compound Methoxybenzene compound
Potential for Dependence None.
Medication Classification Nervous system medication
Mechanism of Action Drugs that block the reabsorption of serotonin and norepinephrine.

FAQs on Arvex-ER 37.5 Capsule

Indeed, Arvex-ER 37.5 Capsules may induce drowsiness. Prior to commencing Arvex-ER 37.5 Capsule therapy, it's crucial to disclose to your physician any concurrent use of sleep-promoting medications.
Indeed. Arvex-ER 37.5mg capsules belong to the class of psychotropic medications. Psychotropic drugs are defined as those substances impacting mental processes, feelings, and actions.
Arvex-ER 37.5 Capsules are not classified as narcotics. Narcotics are opioid-derived substances, such as heroin and morphine, known for their sedative effects.
Arvex-ER 37.5 Capsules, whether ER or XR formulations, are identical medications. Both are extended-release preparations, designed for slow, sustained drug delivery and consistent therapeutic levels. The benefit of extended-release formulations is reduced dosing frequency.
Mirtazapine and Arvex-ER 37.5 Capsule taken concurrently pose a significant risk of serotonin syndrome. This potentially fatal condition manifests with symptoms such as agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, elevated temperature, and coma.
Concomitant use of citalopram and Arvex-ER 37.5 mg capsules, both of which elevate serotonin levels, should be avoided. An alternative medication is recommended to prevent the risk of serotonin syndrome, a potentially fatal condition characterized by symptoms such as agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, fever, and coma.
Arvex-ER 37.5 Capsule is actively removed from the brain by the p-glycoprotein transporter. Research indicates that this medication and its resulting byproduct can suppress p-glycoprotein activity.
Following hepatic metabolism, Arvex-ER 37.5 mg capsules are absorbed into the body via the intestinal tract.
Arvex-ER 37.5mg capsules are prescribed for the management of major depressive disorder. Physician consultation is recommended prior to use.
Treatment with Arvex-ER 37.5 mg capsules may cause a persistent rise in blood pressure in certain individuals. Regular blood pressure checks are advised for patients using Arvex-ER 37.5 mg capsules. A lower dosage or treatment cessation may be necessary for these patients.
Confirmed. Constipation is a reported side effect of Arvex-ER 37.5 Capsules in certain individuals. Increasing dietary fiber and fluid intake is recommended. Laxative use may also be considered. Your physician can advise on preventative or management strategies. Seek medical attention if the constipation persists or worsens.
Indeed, some individuals taking Arvex-ER 37.5 Capsules experience weight reduction. Clinical trials revealed a correlation between dosage and weight loss in patients using this medication for extended periods. Seek medical advice if this side effect is concerning.
Arvex-ER 37.5 mg capsules are not considered habit-forming.
Capsules may be substituted with tablets, but only with a physician's explicit approval. Self-initiated changes are inadvisable, as varying drug formulations affect release rates and, consequently, therapeutic efficacy. This alteration could result in suboptimal treatment, adverse reactions, or treatment failure.
Gabapentin's concurrent use with Arvex-ER 37.5 Capsules requires prior medical consultation. Combined administration may heighten drowsiness, lethargy, and impair concentration. Proceed with caution.
Desvenlafaxine, the active component of Arvex-ER 37.5 Capsule, is the medication in its biologically active state.
The medication Arvex-ER 37.5 Capsule lacks regulatory approval for fibromyalgia treatment. While preliminary research suggests potential benefits in managing fibromyalgia, physician consultation is mandatory before initiating this drug.
Arvex-ER 37.5 Capsules lack regulatory approval for nerve pain, yet studies suggest its effectiveness in managing this condition. Consequently, its application for nerve pain is considered off-label.
Arvex-ER 37.5 mg capsules can alter brain neurotransmitter and chemical levels, resulting in reduced appetite. This appetite suppression is directly related to the dosage administered.
Should you experience reduced libido or erectile dysfunction, consult your physician to explore alternative treatment options. Do not discontinue Arvex-ER 37.5 Capsule without medical supervision; abrupt cessation may worsen side effects.
Arvex-ER 37.5 Capsule
59
MRP 72
18% off